Clinical Trial Update: In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

This is a Phase 2 inpatient trial evaluating GSK716155 in patients with Type 2 diabetes mellitus that has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• GSK716155

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED